Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

. Author manuscript; available in PMC: 2012 Sep 4.
Published in final edited form as: Dev Cell. 2011 Jun 14;20(6):788–801. doi: 10.1016/j.devcel.2011.04.017

Figure 4. Shh-dependent proliferation is completely lost in Gas1−/−;Boc−/− CGNPs.

Figure 4

(A) Haematoxylin-eosin staining on sagittal sections of E18.5 cerebellum revealing a thinner EGL in Gas1−/−;Boc−/− cerebella than control. Anti-pH3 immunostaining of sagittal sections of Gas1+/-;Boc−/− and Gas1−/−;Boc−/− cerebella counterstained with DAPI. RNA in situ hybridization showing the loss of expression of the Shh transcriptional target Gli1 in Gas1−/−;Boc−/− cerebella at E18.5. (B) Quantification of: cerebellum surface area, EGL surface area, pH3+ cells in EGL, pH3+ cells per µm2, and EGL thickness along the postero-anterior axis, n=4 animals/group. (C) CGNPs purified from Gas1+/+;Boc+/+ (n=3), Gas1+/-;Boc+/+ (n=4) and Gas1−/−;Boc+/+ (n=4) mice cerebella at E18.5 were cultured with 0, 3, 10, 30 nM ShhN. Proliferating cells were visualized by immunostaining with an anti-Ki67 antibody. Data is represented as fold CGNP proliferation over untreated control (C, D and E) or DMSO control (F). (D) Similar to (C) but CGNPs were purified from Gas1+/+;Boc−/− (n=3), Gas1+/-;Boc−/− (n=3) and Gas1−/−;Boc−/− (n=3) mice cerebella at E18.5. (E) CGNPs were purified from control (Ctl; Gas1+/+;Boc−/− and Gas1+/-;Boc−/−) (n=3) and Gas1−/−;Boc−/− (n=3) mice cerebella at E18.5 and treated with 0, 20, 50 or 100 ng/ml of IGF-I. (F) Similar to (E) but CGNPs were treated with either DMSO, 0.150 µM purmorphamine, or 30 nM ShhN. p values measured from Student’s t-test (B), two-way ANOVA (C, E), and ANOVA (D, F). EGL, external germinal layer. Scale bars: top two rows=500 µm, bottom two rows=100 µm.

HHS Vulnerability Disclosure